Workflow
Shenzhen YHLO Biotech (688575)
icon
Search documents
证监会对亚辉龙公告涉嫌误导性陈述 立案调查
● 本报记者昝秀丽 证监会2月6日消息,1月7日,深圳市亚辉龙生物科技股份有限公司披露签署战略合作框架协议的公告, 涉嫌误导性陈述。近日,证监会已对亚辉龙立案调查。证监会表示,下一步,将在全面调查的基础上依 法处理,切实维护市场健康发展。 上交所于1月7日发布关于对深圳市亚辉龙生物科技股份有限公司及有关责任人予以监管警示的决定。 经查明,公司于1月6日收盘后披露《关于自愿披露签署战略合作框架协议的公告》称,公司与深圳脑机 星链科技有限公司签订《战略合作框架协议》,双方将在产品研发、市场推广以及股权投资等方面开展 合作,并称脑机星链是一家以人工智能为核心驱动力,深耕非侵入式与侵入式双技术路径的企业,已开 发脑电采集分析仪等产品。该公告披露后,引发媒体报道及市场关注。经上交所督促,公司于当晚又发 布《关于自愿披露签署战略合作框架协议的补充公告》称,脑机星链目前在研产品的技术路线为非侵入 式技术路径,尚无侵入式技术布局,且脑电采集分析仪等产品尚未进入注册申报阶段,有的产品尚处于 早期研发阶段或临床前阶段。 当前"脑机接口"为市场热点概念,为投资者高度关注。特别是,公司股价当日(1月6日)收盘上涨 6.52%、成交量 ...
涉嫌信息披露违法违规两家公司被立案调查
◎记者 王墨璞嘉 张问之 2月6日,亚辉龙、天晟新材因涉嫌信息披露违法违规,被中国证监会立案。其中:亚辉龙因披露签署战 略合作框架协议的公告,涉嫌误导性陈述,被证监会立案;天晟新材则可能涉及2023年度关联交易未披 露事项。 亚辉龙:披露战略合作框架协议涉嫌误导性陈述 2月6日晚间,亚辉龙公告称,收到证监会下发的《立案告知书》,因涉嫌信息披露违法违规,证监会决 定对公司立案调查。 证监会官网显示,亚辉龙披露签署战略合作框架协议的公告,涉嫌误导性陈述。近日,证监会已对亚辉 龙立案调查。下一步,将在全面调查的基础上依法处理,切实维护市场健康发展。 回顾来看,亚辉龙近期发布的公告中,提及与"脑机接口"等热点概念相关的信息,但存在信息披露不准 确、不完整,风险提示不充分等问题。 1月6日收盘后,亚辉龙披露《关于自愿披露签署战略合作框架协议的公告》称,公司与脑机星链签订 《战略合作框架协议》,双方将在产品研发、市场推广以及股权投资等方面开展合作。 涉嫌信息披露违法违规 两家公司被立案调查 亚辉龙公告称,脑机星链是一家以人工智能为核心驱动力,深耕非侵入式与侵入式双技术路径的企业, 已开发脑电采集分析仪等产品。 亚辉龙披露 ...
惩治“蹭热点” 证监会对亚辉龙涉嫌误导性陈述立案调查
Zheng Quan Ri Bao· 2026-02-06 16:41
例如,宁波容百新能源科技股份有限公司披露日常经营重大合同的公告涉嫌误导性陈述,收到证监会立 案调查告知书后,2月6日就收到宁波证监局《行政处罚事先告知书》,宁波证监局拟对公司及相关责任 人罚款合计950万元。 1月9日,证监会表示,宁波市天普橡胶科技股份有限公司股票价格异常波动,市场高度关注。证监会已 对公司股票交易异常波动公告涉嫌重大遗漏立案调查。 此外,今年以来,交易所还对深圳英集芯科技股份有限公司、中电科数字技术股份有限公司、杭萧钢构 股份有限公司、江西沃格光电集团股份有限公司等多家公司"蹭热点"行为采取监管警示。 记者注意到,今年以来,多家上市公司"蹭热点"涉嫌误导性陈述被交易所监管警示、证监会立案调查。 2月6日,证监会发布消息称,对深圳市亚辉龙生物科技股份有限公司(以下简称"亚辉龙")公告涉嫌误 导性陈述立案调查。下一步,证监会将在全面调查的基础上依法处理,切实维护市场健康发展。 往前回溯,亚辉龙于1月6日收盘后发布《关于自愿披露签署战略合作框架协议的公告》称,公司与深圳 脑机星链科技有限公司(以下简称"脑机星链")签订《战略合作框架协议》,双方将在产品研发、市场 推广以及股权投资等方面开展合作, ...
2月9日A股投资避雷针︱天晟新材:因涉嫌信息披露违法违规 证监会对公司立案
Ge Long Hui A P P· 2026-02-06 14:46
Core Viewpoint - Several shareholders across various companies are planning to reduce their stakes, indicating potential shifts in ownership and investor sentiment in the market [1] Shareholder Reductions - Xuelang Environment's shareholders Yang Jianping and Xu Huifen plan to reduce their holdings by no more than 3% [1] - Dajia Weikang's actual controller's concerted actors also intend to reduce their stakes by no more than 3% [1] - Zhongfutong's shareholders, including Changde Zhongke, Zhejiang Zhongke, and Jinjiang Ronglei, plan to collectively reduce their holdings by no more than 0.68% [1] - Huitong Technology's directors Zhong Ming and Yang Jian plan to reduce their stakes by no more than 1.64% [1] - Shuangjie Electric's director Xu Zhuan intends to reduce his holdings by no more than 378.9 thousand shares [1] - Hu Silicon Industry's shareholder investment fund plans to reduce its holdings by no more than 99.15 million shares [1] - Zhongji United's director and senior vice president Ma Dongsheng plans to reduce his holdings by no more than approximately 110 thousand shares [1] - Lushan New Materials' shareholders Lushan Information and Wang Jiasheng plan to collectively reduce their stakes by no more than 3% [1] - Zhidi Technology's Zhikong Investment plans to reduce its holdings by no more than 24.18 thousand shares [1] - Yinxin Technology's directors and senior management plan to collectively reduce their holdings by no more than 242.7 thousand shares [1] - Huizhi Micro's shareholder Great Fund Phase II plans to reduce its holdings by 0.57542% [1] - Jingda Shares' shareholder Li Guangrong and concerted actors have already collectively reduced their holdings by 64.3 million shares [1] - Huashu High-tech's shareholder Xingwang Construction has reduced its holdings by 236.81 thousand shares [1] Regulatory Actions - Tiansheng New Materials is under investigation by the China Securities Regulatory Commission (CSRC) for suspected violations of information disclosure [1] - Yahui Long is also under investigation by the CSRC for suspected violations of information disclosure [1]
688575,被证监会立案!
Zhong Guo Ji Jin Bao· 2026-02-06 13:39
中国基金报记者 张舟 2月6日晚间,又有上市公司被证监会立案! 据中国证监会官网消息,2026年1月7日,深圳市亚辉龙生物科技股份有限公司(以下简称亚辉龙)披露签署战略合作框架协议的公告,涉嫌误导性陈述。 近日,证监会已对亚辉龙立案调查。下一步,将在全面调查的基础上依法处理,切实维护市场健康发展。 亚辉龙当晚发布公告称,公司已于2026年2月6日收到中国证监会下发的《立案告知书》,因公司涉嫌信息披露违法违规,中国证监会决定对公司立案。 登录新浪财经APP 搜索【信披】查看更多考评等级 【导读】亚辉龙被中国证监会立案 亚辉龙对此表示,目前公司各项经营活动和业务均正常开展。立案调查期间,公司将积极配合中国证监会的相关工作,并严格按照相关法律法规和监管要 求及时履行信息披露义务。 截至2月6日收盘,亚辉龙日内跌0.55%,股价报14.45元/股,最新市值为83亿元,最新股东户数为1.28万户。 编辑:格林 校对:王玥 制作:舰长 审核:木鱼 ...
亚辉龙,涉嫌误导性陈述!被立案调查
证监会2月6日消息,1月7日,深圳市亚辉龙生物科技股份有限公司披露签署战略合作框架协议的公告,涉嫌误导性陈述。近日,证监会已对亚辉龙立案调 查。 该公告披露后,引发媒体报道及市场关注。经上交所督促,公司于当晚又发布《关于自愿披露签署战略合作框架协议的补充公告》称,脑机星链目前在研 产品的技术路线为非侵入式技术路径,尚无侵入式技术布局,且脑电采集分析仪等产品尚未进入注册申报阶段,有的产品尚处于早期研发阶段或临床前阶 段。 上交所表示,当前,"脑机接口"为市场热点概念,投资者高度关注。特别是,公司股价当日(1月6日)收盘上涨6.52%、成交量较前一个交易日增长 299%,公司披露涉及热点相关信息尤其应当审慎,确保相关信息披露真实、准确、完整,避免对投资者产生误导。公司相关公告对合作方脑机星链技术 路径是否包含侵入式的表述前后不一致,也未就合作协同性、可行性以及后续合作不确定性等投资者关注的重点事项进行充分提示风险,信息披露不准 确、不完整。 公司上述行为违反了《上海证券交易所科创板股票上市规则》相关条款,以及《上海证券交易所科创板上市公司自律监管指引第2号——自愿信息披露》 等有关规定。公司时任董事会秘书王鸣阳作 ...
一科创板公司被立案调查!蹭“脑机接口”热点?2025年归母净利润同比下降超90%
梧桐树下V· 2026-02-06 12:57
文/梧桐晓编 2月6日,中国证监会官网公布:证监会对亚辉龙公告涉嫌误导性陈述立案调查。2026年1月7日,深圳市亚辉龙生物科技股份有限公司(688575)披露签署战略合 作框架协议的公告,涉嫌误导性陈述。近日,证监会已对亚辉龙立案调查。下一步,将在全面调查的基础上依法处理,切实维护市场健康发展。亚辉龙也于2月6 日晚间公告收到证监会下发的《立案告知书》。 亚辉龙于2021年5月17日上市。公司主营业务为:以化学发光免疫分析法为主的体外诊断仪器及配套试剂的研发、生产和销售, 及部分非自产医疗器械产品的代理 销售业务。 2026年1月7日,亚辉龙发布《关于自愿披露签署战略合作框架协议的公告》。亚辉龙于1月6日与深圳脑机星链科技有限公司(以下简称:"脑机星链")签署了《战 略合作框架协议》。而脑机星链在2025年9月2日才成立,注册资本500万元,共有4名股东,主营业务:包括脑疾病综合诊断、治疗与康复,集研究、开发、生 产、销售、技术支持一体化等业务。亚辉龙通过深圳市焕生纪生物科技有限公司间接持有脑机星链 4%的股权。 | 序号 | 股东名称 | 持股比例(%) | | --- | --- | --- | | | ...
A股公告精选 | 亚辉龙(688575.SH)因涉嫌信息披露违法违规 被证监会立案
智通财经网· 2026-02-06 12:41
Group 1 - Heng Rui Medicine's HRS-4642 injection has been included in the list of breakthrough therapeutic varieties, aimed at treating advanced or metastatic pancreatic cancer with KRAS G12D mutation in combination with gemcitabine and albumin-bound paclitaxel, with a total R&D investment of approximately 254 million yuan [1] - Fenglong Co. announced a significant stock price increase of 491.97% from December 25, 2025, to February 5, 2026, and may apply for a trading suspension if prices continue to rise abnormally [2] - Aier Eye Hospital clarified that the reported Xiangyang Hengtai Kang is not affiliated with the company, but is a joint venture established by Aier Medical Investment Group and other investors [3] Group 2 - XWANDA's subsidiary reached a settlement with Weir Electric, which is expected to impact the company's net profit attributable to shareholders by 500 million to 800 million yuan in 2025 [4] - Tianzhong Precision Machine received a lawsuit from eight creditors of its former subsidiary, involving a claim of 108 million yuan [5] - Dongtian Micro plans to invest 400 million yuan to establish a global R&D center and manufacturing headquarters in Dongguan, focusing on precision optical components for optical communication [6] Group 3 - Lvtong Technology's industrial fund plans to invest 10 million yuan in Shenghao Optoelectronics, which specializes in testing equipment for optical communication chips [7] - Tiansheng New Materials has been investigated by the China Securities Regulatory Commission for suspected violations of information disclosure laws [8] - Yahui Long has been placed under investigation by the CSRC for suspected information disclosure violations [9] Group 4 - Longyun Co. plans to acquire 58% of Yuheng Film Industry through a share issuance, with the target company's valuation estimated between 450 million and 530 million yuan [10] - Hu Silicon Industry announced that the National Integrated Circuit Industry Investment Fund plans to reduce its stake by up to 3% [11] - Perfect World reported that its actual controller has reduced his stake by 1.70% through various transactions [12] Group 5 - Sanfu Co. announced that its shareholder, Tangshan Yuanheng Technology Co., intends to reduce its stake by up to 3% [13] - Wanshan Expressway plans to invest 5.42 billion yuan in the expansion of the G30 Lianhuo Expressway in Anhui [14] - New Hope reported sales of 1.1218 million pigs in January, generating revenue of 1.628 billion yuan [15]
晚间公告|2月6日这些公告有看头
Di Yi Cai Jing· 2026-02-06 12:11
Company Announcements - Tongde Chemical's assets in Beijing have been frozen due to a financing lease contract dispute with Zhejiang Zhiyin Financial Leasing Co., Ltd. The company is in communication to resolve the issue while maintaining normal operations [3] - Jindi Co. plans to acquire 100% equity of Guangzhou Yuni Precision Co., Ltd. for 116 million yuan, focusing on precision stamping products for automotive applications [4] - XWANDA's subsidiary reached a settlement in a lawsuit involving 2.314 billion yuan, with an expected impact on the company's net profit of 500 million to 800 million yuan for 2025 [5] - Wantong Expressway intends to invest approximately 5.42 billion yuan in the renovation and expansion of the Lianhuo Expressway, with construction expected to start in 2026 [6] - ZTE Corporation plans to invest 200 million yuan in the Guangdong-Hong Kong-Macao Greater Bay Area Venture Capital Fund, which focuses on technology and manufacturing sectors [7] - Fawer Automotive Components has completed the relocation of its Chongqing factory, which will enhance production capacity to 4 million shock absorbers annually [8] - YHLO has been investigated by the China Securities Regulatory Commission for suspected information disclosure violations, but its operations remain normal [9] - Crystal Integrated plans to invest 2 billion yuan to acquire 100% equity of Anhui Jingyi Integrated Circuit Co., Ltd., focusing on advanced semiconductor manufacturing [10] - Dongtian Micro plans to invest 400 million yuan in a global R&D center and manufacturing headquarters in Dongguan [11] Performance Reports - New Hope reported a January sales revenue of 1.628 billion yuan from 1.1218 million pigs, a year-on-year decline of 10.03% [13] - Tianbang Foods achieved a January sales revenue of 674 million yuan from 682,000 pigs, with a year-on-year increase of 9.93% [14] - Guoji General reported a net profit of 58.5157 million yuan for 2025, a year-on-year increase of 45.71% [15] - Zhongtong Bus sold 1,231 vehicles in January, marking a year-on-year growth of 35.72% [16] - Kunming Pharmaceutical Group reported a net profit of 350 million yuan for 2025, a year-on-year decline of 46% [17] - Focus Technology achieved a net profit of 504 million yuan for 2025, a year-on-year increase of 11.73% [18] - China Shipbuilding Special Gas reported a net profit of 347 million yuan for 2025, a year-on-year increase of 12.92% [20] Shareholding Changes - Lushan New Materials' controlling shareholder plans to reduce its stake by up to 3% [22] - Zhongji United's two directors plan to reduce their holdings by up to 0.91% [23] - Dajia Weikang's controlling shareholder plans to reduce its stake by up to 3% [24] - Hu Silicon Industry's National Integrated Circuit Industry Investment Fund plans to reduce its stake by up to 3% [25] Major Contracts - Chuangyuan Technology's subsidiary is a recommended candidate for a National Grid project with a pre-bid amount of 94.7672 million yuan [27]
688575、300169,被证监会立案!
证券时报· 2026-02-06 11:54
两家公司遭证监会立案调查。 2月6日晚间,亚辉龙(688575)、天晟新材(300169)发布公告称,收到中国证监会下发的《立案告知书 》 ,因公司涉嫌信息披露违法违规, 中国证监会决定对公司立案。 证监会对亚辉龙公告涉嫌误导性陈述立案调查 据中国证监会网站消息,2026年1月7日,深圳市亚辉龙生物科技股份有限公司(简称"亚辉龙")披露签署战略合作框架协议的公告,涉嫌误导性 陈述。近日,证监会已对亚辉龙立案调查。下一步,将在全面调查的基础上依法处理,切实维护市场健康发展。 据悉,1月6日盘后,亚辉龙发布签署战略合作框架协议的公告称,于近日与深圳脑机星链科技有限公司(以下简称"脑机星链")签署了《战略合 作框架协议》。当天,上交所火速下发问询函,随后,上交所对公司及有关责任人予以监管警示。 责编:万健祎 校对: 刘榕枝 上交所表示,当前"脑机接口"为市场热点概念,为投资者高度关注。特别是,公司股价当日收盘上涨6.52%、成交量较前一个交易日增长299%, 公司披露涉及热点相关信息尤其应当审慎,确保相关信息披露真实、准确、完整,避免对投资者产生误导。公司相关公告对合作方脑机星链技术 路径是否包含侵入式的表述前后不 ...